Description
Humira 40mg Injection Pen (Adalimumab) – AbbVie
Humira 40mg injection is the original adalimumab biologic manufactured by AbbVie, supplied as a 40mg/0.4mL solution in a prefilled syringe for subcutaneous use. At Ahmad Medico, you get genuine AbbVie stock, sourced through licensed distributors and shipped under verified cold-chain conditions so the biologic reaches you exactly as it left the manufacturer.
If your rheumatologist, dermatologist, or gastroenterologist has prescribed this treatment, our pharmacist team confirms your prescription, checks the batch and expiry, and packs your order for temperature-controlled delivery.
What Is Humira and How Does It Work?
Adalimumab is a recombinant human monoclonal antibody that belongs to a class of biologics called TNF-alpha inhibitors. Your body produces a protein called tumour necrosis factor alpha (TNF-alpha) as part of a normal immune response, but in autoimmune disease, this protein is overproduced and attacks healthy joints, skin, and gut tissue.
Adalimumab binds specifically to TNF-alpha and blocks its interaction with cell-surface receptors, so the downstream inflammation, joint damage, and tissue destruction slow down. This mechanism places adalimumab at the centre of autoimmune disease treatment for several chronic inflammatory conditions, often alongside methotrexate for better antibody control and longer-lasting response.
Humira Injection Uses
Doctors prescribe Humira injection for a range of inflammatory and autoimmune conditions, including:
- Rheumatoid arthritis, often combined with methotrexate for patients with an inadequate response to disease-modifying drugs
- Polyarticular juvenile idiopathic arthritis (from 2 years of age) and enthesitis-related arthritis (from 6 years of age)
- Psoriatic arthritis and axial spondyloarthritis, including ankylosing spondylitis
- Moderate to severe chronic plaque psoriasis, including paediatric plaque psoriasis from 4 years of age
- Hidradenitis suppurativa in adults and adolescents from 12 years of age
- Crohn’s disease and ulcerative colitis, in both adult and paediatric patients from 6 years of age
- Non-infectious uveitis, including paediatric uveitis from 2 years of age
Each condition responds to adalimumab differently, and your specialist decides which one applies to your case based on your diagnosis, disease activity, and response to earlier treatments such as methotrexate, corticosteroids, or NSAIDs.
Dosage of Humira 40mg Injection
Your dosage depends entirely on your condition and body weight, so never adjust your dose or frequency without your doctor’s direction. As a general reference:
- Rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and axial spondyloarthritis: 40mg subcutaneously every other week; some patients with a reduced response may move to 40mg weekly under medical supervision
- Crohn’s disease: typically 160mg on Day 1, 80mg on Day 15, then 40mg every other week from Day 29
- Ulcerative colitis: 160mg at Week 0, 80mg at Week 2, then 40mg every other week
- Plaque psoriasis: an initial dose of 80mg, followed by 40mg every other week starting one week later
- Hidradenitis suppurativa: 160mg initially (Day 1), 80mg two weeks later (Day 15), then 40mg weekly or 80mg every other week from Day 29
- Uveitis: an initial dose of 80mg, followed by 40mg every other week starting one week later
- Paediatric dosing for JIA, Crohn’s disease, ulcerative colitis, psoriasis, and uveitis is calculated by body weight or body surface area, so this must be set by a paediatric specialist
Your first injection should be administered or supervised by a doctor or nurse. After that, the pen is designed for self-injection into the thigh or abdomen, and you should rotate injection sites each time to reduce site reactions. Clinical response is usually assessed within 12 to 16 weeks, and your doctor may reconsider continued therapy if you show no improvement within that window.
Who Should Not Use Humira
Your doctor rules out Humira if you have any of the following:
- A known hypersensitivity to adalimumab or any excipient in the formulation
- Active tuberculosis or other severe infections, including sepsis or opportunistic infections
- Moderate to severe heart failure (NYHA class III/IV)
Humira should also be used cautiously, and only under close monitoring, if you have mild heart failure, a history of demyelinating disease such as multiple sclerosis, a history of cancer, or a history of recurring infections.
Essential Safety Information
Before you start Humira, your doctor screens you for tuberculosis and hepatitis B, since adalimumab can reactivate infections that were previously dormant, sometimes months after your last dose because adalimumab clears slowly from your system. Tell your doctor about any current infection, fever, recent travel to a high-risk region for tuberculosis or fungal infections, or a planned surgery, since treatment may need to pause around a procedure.
Avoid live vaccines while on treatment; this includes the BCG vaccine for infants born to mothers who received adalimumab during pregnancy, which should be delayed for five months after the mother’s last dose. If you develop signs of a serious infection or allergic reaction, get medical help right away rather than continuing your dose.
Humira Injection Side Effects
Like any biologic, adalimumab carries a documented side-effect profile, and your doctor weighs these against your condition before prescribing it.
Common side effects:
- Injection-site reactions, redness, pain, swelling, itching, or bruising
- Headache and musculoskeletal pain
- Upper respiratory tract infections, including nasopharyngitis and sinusitis
- Skin rash
Serious side effects (seek medical attention if these occur):
- Serious infections, including tuberculosis, bacterial sepsis, and invasive fungal infections
- Increased cancer risk, including lymphoma and, rarely, hepatosplenic T-cell lymphoma
- Severe allergic reactions, including anaphylaxis
- Hepatitis B reactivation in prior carriers
- Neurological symptoms such as numbness, vision changes, or weakness, linked in rare cases to demyelinating conditions
- Blood disorders, including low platelet count and anaemia
- New or worsening congestive heart failure
- Lupus-like symptoms such as joint pain, rash, and fever
Report any of these to your doctor immediately rather than waiting for your next scheduled visit. In clinical trials, roughly 1 in 8 patients experienced an injection-site reaction, and most did not need to stop treatment because of it.
Interactions You Should Discuss With Your Doctor
Adalimumab is commonly combined with methotrexate, which lowers antibody formation against adalimumab and improves its efficacy compared to using adalimumab alone. Combining Humira with other biologic DMARDs such as anakinra or abatacept is not recommended, since this raises the risk of serious infection without added benefit.
Also tell your doctor if you take azathioprine or 6-mercaptopurine, as this combination has been linked to a higher rate of malignancy and serious infection in Crohn’s disease patients. Because Humira affects immune response, discuss any planned vaccination with your doctor beforehand, since live vaccines are not permitted during treatment.
Pregnancy, Breastfeeding, and Fertility
If you are of childbearing potential, use adequate contraception during treatment and for at least five months after your last dose. Large pregnancy registries covering thousands of adalimumab-exposed pregnancies have not shown an increased rate of birth defects compared to the general population, though adalimumab should only be used in pregnancy if clearly needed, since it crosses the placenta and could affect the newborn’s immune response.
Adalimumab passes into breast milk only in very small amounts, and current evidence does not point to any effect on breastfed infants, so Humira can generally be used while breastfeeding; confirm this with your doctor first.
Composition and Pack Sizes
Each 0.4mL prefilled syringe contains 40mg of adalimumab along with mannitol, polysorbate 80, and water for injections. Humira is supplied as packs of 1, 2, 4, or 6 prefilled syringes, each accompanied by an alcohol pad, though not every pack size is available at all times. Shelf life is 2 years when stored correctly.
Storage Instructions
Adalimumab is a biologic, so temperature control protects its effectiveness from the moment it leaves the factory until the moment you inject it.
- Refrigerate at 2–8°C in the original carton
- Never freeze the pen or syringe
- Protect it from light at all times
- A single syringe may be kept at up to 25°C for a maximum of 14 days if needed; note the date it left the fridge and discard it if unused within that window
At Ahmad Medico, every Humira order ships in a validated cold-chain container with ice packs and insulation, and we recommend refrigerating it as soon as it arrives.
Humira 40mg Injection Price in Pakistan
The Humira 40mg injection price in Pakistan reflects its status as an imported biologic, and pricing shifts with exchange rates and available batch stock. The current Humira injection price is listed above per 40mg/0.4mL syringe, and our pharmacist confirms the exact figure with you before your order is processed, so there are no surprises at checkout.
Why Buy Humira Online in Pakistan From Ahmad Medico?
- DRAP-registered pharmacy, legally licensed to dispense prescription medicines
- Pharmacist verification on every prescription before dispatch
- Cold-chain shipping with insulated packaging and ice packs nationwide
- Discreet plain packaging, no product details visible on the outer box
- Free pharmacist consultation by WhatsApp or phone for any questions about your order
Frequently Asked Questions
Is Humira available in Pakistan?
Yes. Ahmad Medico sources AbbVie Humira through licensed importers and authorised distributors, then delivers it nationwide with cold-chain packaging intact from dispatch to your doorstep.
Does Humira need refrigeration during delivery?
Yes. Adalimumab must stay between 2–8°C, and we ship every order in a validated cold-chain container. Refrigerate it as soon as it arrives at your address.
Is there a cheaper alternative to Humira?
Hyrimoz 40mg, an approved adalimumab biosimilar, is available at a lower price. Ask your doctor whether switching from the originator biologic is appropriate for your condition.
Who should avoid Humira?
Anyone with active tuberculosis, an untreated serious infection, or moderate to severe heart failure should not start Humira. Your doctor screens for these before your first dose.
Can I take Humira with other medicines?
Many patients take Humira alongside methotrexate, and your doctor may continue corticosteroids or NSAIDs during treatment. Avoid combining Humira with other biologic DMARDs, and confirm any new medication with your doctor first.
How do I know my dosage is correct?
Your specialist sets your dosage and schedule based on your diagnosis and body weight, and it can change over time depending on how you respond to treatment. Never alter your dose without medical guidance.
————————————————————————————————————————————
Medical disclaimer: This page is for educational purposes only and does not replace advice from your treating specialist or pharmacist. Always consult your doctor before starting, stopping, or adjusting any biologic treatment.
